Article
Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance
23 Mar 2019
Abstract excerpt
Cholangiocarcinoma (CCA) is a deadly disease. While surgery may attain cure in a minor fraction of cases, therapeutic options in either the adjuvant or advanced setting are limited. The possibility of advancing the efficacy of therapeutic approaches to CCA relies on understanding its molecular pathogenesis and developing rational therapies aimed at interfering with oncogenic signalling networks that drive and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
